‘Sound of Falling’ Review: Four Generations of German Girls Suffer the Same Growing Pains in Mascha Schilinski’s Mesmerizing Stunner

Unfolding like 100 years of home video footage that were shot by the family ghosts, Mascha Schilinski’s rich and mesmeric “ ...
Security Boulevard

RBAC vs ReBAC: Comparing Role-Based & Relationship-Based Access Control

Deep dive into RBAC vs ReBAC for enterprise sso. Learn which authorization model fits your ciam strategy and how to avoid role explosion in complex apps.

Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab

AI chipmaker Nvidia (NVDA) and pharmaceutical giant Eli Lilly (LLY) on Monday announced that the two companies would jointly invest $1 billion to create a lab in San Francisco focused on using AI to ...
pharmaphorum

Recursion, Exscientia, and AI drug discovery’s moment of truth

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
pharmaphorum

AI biotechs Exscientia and Recursion agree $688m merger

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Barron's

Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...